Literature DB >> 4696745

Propranolol and hypertriglyceridemia.

J J Barboriak, H D Friedberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4696745     DOI： 10.1016/0021-9150(73)90132-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  8 in total

Review 1.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

2.  Failure of the nonselective beta-blocker propranolol to affect lipoprotein lipase gene expression in the rat.

Authors:  I Gouni-Berthold; K Oka; H K Berthold; L Chan
Journal:  Lipids       Date:  1997-09       Impact factor: 1.880

Review 3.  The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

Review 4.  Serum lipoproteins during treatment with antihypertensive drugs.

Authors:  P Weidmann; C Ferrier; H Saxenhofer; D E Uehlinger; B N Trost
Journal:  Drugs       Date:  1988       Impact factor: 9.546

5.  Beta adrenoceptor blockade and responses of serum lipids to a meal and to exercise.

Authors:  N R Peden; R J Dow; T E Isles; B T Martin
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-16

6.  Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.

Authors:  J L Day; N Simpson; J Metcalfe; R L Page
Journal:  Br Med J       Date:  1979-01-13

Review 7.  Thiazides, beta blockers and lipoproteins.

Authors:  D Ballantyne; F C Ballantyne
Journal:  Postgrad Med J       Date:  1983-08       Impact factor: 2.401

Review 8.  Lipids, lipoproteins, and coronary heart disease: implications for antihypertensive therapy.

Authors:  M D Feher; D J Betteridge
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.